Browse Category

Solutions - Page 5

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

As biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: report

As biologics have increasingly superseded small molecules in the biopharma industry’s pipeline, the mounting complexity of their manufacturing products is putting production and launches under pressure.

May 15, 2026

News·Solutions

Sun recalls US chemotherapy batch, citing glass particle contamination concerns

Generics juggernaut Sun Pharma is pulling one lot of a chemotherapy drug in the United States as the issue of particulate contamination crops up once again on the FDA’s recall register.

May 14, 2026

News·Solutions

Bora snaps up MacroGenics’ manufacturing, CDMO operations for up to $127.5M

Taiwan’s Bora Group will shell out up to $127.5 million to acquire the CDMO business and manufacturing operations from Maryland-based MacroGenics.

May 14, 2026

News·Solutions

EU advances scheme to bolster manufacturing autonomy, avert drug shortages

After positive momentum on the plan in late 2025, European Union lawmakers have taken a critical step toward implementing a new framework for the bloc focused on boosting supplies of critical medicines

May 12, 2026

News·Solutions

Maintaining trust in medical AI: Monitoring and managing model lifecycle

Artificial intelligence (AI) is transforming the HealthTech landscape. Advanced algorithms are increasingly embedded within medical devices, clinical decision support platforms and digital patient management systems, enabling healthcare organizations to use specialist AI

May 11, 2026

Solutions

FDA rolls out 1-day assessment pilot in bid to refocus inspection resources

In a bid to better deploy its boots-on-the-ground resources, the FDA is rolling out a new pilot program, under which the regulator is leveraging “one-day inspectional assessments” to complement its traditional site

May 6, 2026

News·Solutions

The timing is right for psychedelics manufacturer Optimi Health’s IPO

Last month, when Optimi Health kicked off an initial public offering of 2.5 million shares, the timing couldn’t have been better for the Vancouver-based manufacturer of psychedelic drugs. With President Donald Trump recently signing

May 6, 2026

News·Solutions

Lilly to invest $4.5B more into massive Indiana manufacturing complex

With commitments to invest more than $50 billion in building up its U.S. manufacturing presence, Eli Lilly has earmarked an additional $4.5 billion to upgrade two of its three planned production facilities

May 6, 2026

News·Solutions

Novartis to close German manufacturing site, cutting 220 jobs

Novartis is continuing its multiyear overhaul with new plans to shutter its production facility in Wehr, Germany, by 2028. The move, announced Tuesday, will eliminate about 220 jobs, according to Novartis.

May 5, 2026

News·Solutions

BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback

The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore, putting as many as 1,860 jobs on the chopping block.

May 5, 2026

News·Solutions

Previous 1 … 3 4 5 6 7 … 22 Next

Go toTop